In vitro assays in natural products research – a matter of concentration and relevance to in vivo administration using resveratrol, α-mangostin/γ-mangostin and xanthohumol as examples

References

• Almeida L, Vaz-da-Silva M, Falcão A, Soares E, Costa R, Loureiro AI, Fernandes-Lopes C, Rocha JF, Nunes T, Wright L, et al. 2009. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res. 53 (Suppl 1):S7–S15.10.1002/mnfr.v53.5s
   Web of Science ®Google Scholar
• Autenrieth CS, Baumert J, Baumeister SE, Fischer B, Peters A, Döring A, Thorand B. 2011. Association between domains of physical activity and all-cause, cardiovascular and cancer mortality. Eur J Epidemiol. 26:91–99.10.1007/s10654-010-9517-6
   PubMed Web of Science ®Google Scholar
• Balunas MJ, Su B, Brueggemeier RW, Kinghorn AD. 2008. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J Nat Prod. 71:1161–1166.10.1021/np8000255
   PubMed Web of Science ®Google Scholar
• Bellavia A, Larsson SC, Bottai M, Wolk A, Orsini N. 2013. Fruit and vegetable consumption and all-cause mortality: a dose-response analysis. Am J Clin Nutr. 98:454–459.10.3945/ajcn.112.056119
   PubMed Web of Science ®Google Scholar
• Bo S, Ciccone G, Castiglione A, Gambino R, De Michieli F, Villois P, Durazzo M, Cavallo-Perin P, Cassader M. 2013. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem. 20:1323–1331.10.2174/0929867311320100009
   PubMed Web of Science ®Google Scholar
• Bolca S, Li J, Nikolic D, Roche N, Blondeel P, Possemiers S, De Keukeleire D, Bracke M, Heyerick A, van Breemen RB, et al. 2010. Disposition of hop prenylflavonoids in human breast tissue. Mol Nutr Food Res. Jul;54 (Suppl 2):S284–S294.10.1002/mnfr.v54.7s
   PubMed Web of Science ®Google Scholar
• Bollmann F, Art J, Henke J, Schrick K, Besche V, Bros M, Li H, Siuda D, Handler N., Bauer F, et al. 2014. Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activity. Nucleic Acids Res. 42:12555–12569.10.1093/nar/gku1033
   PubMed Web of Science ®Google Scholar
• Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, et al. 2007. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 16:1246–1252.10.1158/1055-9965.EPI-07-0022
   PubMed Web of Science ®Google Scholar
• Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, et al. 2010. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 70:9003–9011.10.1158/0008-5472.CAN-10-2364
   PubMed Web of Science ®Google Scholar
• Bulun SE, Lin Z, Zhao H, Lu M, Amin S, Reierstad S, Chen D. 2009. Regulation of aromatase expression in breast cancer tissue. Ann N Y Acad Sci. 1155:121–131.10.1111/j.1749-6632.2009.03705.x
   PubMed Web of Science ®Google Scholar
• Calamini B, Ratia K, Malkowski MG, Cuendet M, Pezzuto JM, Santarsiero BD, Mesecar AD. 2010. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J. 429:273–282.10.1042/BJ20091857
   PubMed Web of Science ®Google Scholar
• Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O’Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, et al. 2014. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2092–2103:e2091–e2096.10.1016/j.cgh.2014.02.024
   Google Scholar
• Chang J. 2000. Medicinal herbs: drugs or dietary supplements? Biochem Pharmacol. 59:211–219.10.1016/S0006-2952(99)00243-9
   PubMed Web of Science ®Google Scholar
• Chitchumroonchokchai C, Riedl KM, Suksumrarn S, Clinton SK, Kinghorn AD, Failla ML. 2012. Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. J Nutr. 142 :675–680.10.3945/jn.111.156992
   PubMed Web of Science ®Google Scholar
• Choi YH, Han SY, Kim YJ, Kim YM, Chin YM. 2014. Absorption, tissue distribution, tissue metabolism and safety of α-mangostin in mangosteen extract using mouse models. Food Chem Toxicol. 66 :140–146.10.1016/j.fct.2014.01.028
   PubMed Web of Science ®Google Scholar
• Cristofoletti R, Dressman JB. 2014. Use of physiologically based pharmacokinetic models coupled with pharmacodynamic models to assess the clinical relevance of current bioequivalence criteria for generic drug products containing Ibuprofen. J Pharm Sci. 103:3263–3275.10.1002/jps.24076
   PubMed Web of Science ®Google Scholar
• Dildy T. 2015. Evidence for and against dietary recommendations to prevent cardiovascular disease. Tex Heart Inst J. 42:234–236.10.14503/THIJ-15-5072
   PubMed Web of Science ®Google Scholar
• Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. 2014. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 34:837–843.10.1016/j.nutres.2014.09.005
   PubMed Web of Science ®Google Scholar
• Farzaneh V, Carvalho IS. 2015. A review of the health benefit potentials of herbal plant infusions and their mechanism of actions. Ind Crops Prod. 65:247–258.10.1016/j.indcrop.2014.10.057
   Web of Science ®Google Scholar
• Fernández-Mar MI, Mateos R, García-Parrilla MC, Puertas B, Cantos-Villar E. 2012. Bioactive compounds in wine: resveratrol, hydroxytyrosol and melatonin: a review. Food Chem. 130:797–813.10.1016/j.foodchem.2011.08.023
   Web of Science ®Google Scholar
• Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ. 2005. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. 14:120–125.
   PubMed Web of Science ®Google Scholar
• Goh KP, Lee HY, Lau DP, Supaat W, Chan YH, Koh AF. 2014. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure. Int J Sport Nutr Exerc Metab. 24:2–13.10.1123/ijsnem.2013-0045
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Ng E, Yan J, Karumanchiri A, Soleas GJ, Diamandis EP. 1996. Regional differences in resveratrol isomer concentrations of wines from various cultivars. J Wine Res. 7:13–24.10.1080/09571269608718057
   Google Scholar
• Goldberg DM, Yan J, Soleas GJ. 2003. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem. 36:79–87.10.1016/S0009-9120(02)00397-1
   PubMed Web of Science ®Google Scholar
• Gu X, Creasy L, Kester A, Zeece M. 1999. Capillary electrophoretic determination of resveratrol in wines. J Agric Food Chem. 47:3223–3227.10.1021/jf981211e
   PubMed Web of Science ®Google Scholar
• Gutierrez-Orozco F, Failla ML. 2013. Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence. Nutrients. 5:3163–3183.10.3390/nu5083163
   PubMed Web of Science ®Google Scholar
• Hausenblas HA, Schoulda JA, Smoliga JM. 2015. Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus–systematic review and meta-analysis. Mol Nutr Food Res. 59:147–159.10.1002/mnfr.v59.1
   PubMed Web of Science ®Google Scholar
• Hoshino J, Park EJ, Kondratyuk TP, Marler L, Pezzuto JM, van Breemen RB, Mo S, Li Y, Cushman M. 2010. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J Med Chem. 53:5033–5043.10.1021/jm100274c
   PubMed Web of Science ®Google Scholar
• Kalmar JM. 2005. The influence of caffeine on voluntary muscle activation. Med Sci Sports Exerc. 37:2113–2119.10.1249/01.mss.0000178219.18086.9e
   PubMed Web of Science ®Google Scholar
• Kondo M, Zhang L, Ji H, Kou Y, Ou B. 2009. Bioavailability and antioxidant effects of a xanthone-rich mangosteen (Garcinia mangostana) product in humans. J Agric Food Chem. 57:8788–8792.10.1021/jf901012f
   PubMed Web of Science ®Google Scholar
• Kopp P. 1998. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the ‘French paradox’? Eur J Endocrinol. 138:619–620.10.1530/eje.0.1380619
   PubMed Web of Science ®Google Scholar
• Lambert JD, Lee MJ, Diamond L, Ju J, Hong J, Bose M, Newmark HL, Yang CS. 2006. Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab Dispos. 34:8–11.
   PubMed Web of Science ®Google Scholar
• Legette L, Karnpracha C, Reed RL, Choi J, Bobe G, Christensen JM, Rodriguez-Proteau R, Purnell JQ, Stevens JF. 2014. Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Mol Nutr Food Res. 58:248–255.10.1002/mnfr.v58.2
   PubMed Web of Science ®Google Scholar
• Li S, Bouzar C, Cottet-Rousselle C, Zagotta I, Lamarche F, Wabitsch M, Tokarska-Schlattner M, Fischer-Posovszky P, Schlattner U, Rousseau D. 2016. Resveratrol inhibits lipogenesis of 3 T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase. Biochim Biophys Acta. 1857:643–652.
   PubMed Web of Science ®Google Scholar
• Liang Y, Tian W, Ma X. 2013. Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase. BMC Complement Altern Med. 13:361.10.1186/1472-6882-13-361
   PubMed Web of Science ®Google Scholar
• Lindstrom A, Ooyen C, Lynch ME, Blumenthal M, Kawa K. 2014. Sales of herbal dietary supplements increase by 7.9% in 2013, marking a decade of rising sales: turmeric supplements climb to top ranking in natural channel. Available from: http://cms.herbalgram.org/press/2014/2013_Herb_Market_Report.html?ts=1455394693&signature=5de88c798ce97e94358b796894af4e7f.
   Google Scholar
• Lyles JT, Negrin A, Khan SI, He K, Kennelly EJ. 2014. In vitro antiplasmodial activity of benzophenones and xanthones from edible fruits of Garcinia species. Planta Med. 80:676–681.
   PubMed Web of Science ®Google Scholar
• Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. 2012. Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc. 50:179–187.
   PubMed Web of Science ®Google Scholar
• Monteiro R, Becker H, Azevedo I, Calhau C. 2006. Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. J Agric Food Chem. 54:2938–2943.10.1021/jf053162t
   PubMed Web of Science ®Google Scholar
• Monteiro R, Faria A, Azevedo I, Calhau C. 2007. Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J Steroid Biochem Mol Biol. 105:124–130.10.1016/j.jsbmb.2006.11.026
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Miyazawa T. 1997. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol (Tokyo). 43:679–684.10.3177/jnsv.43.679
   PubMed Web of Science ®Google Scholar
• Ornstrup MJ, Harsløf T, Kjær TN, Langdahl BL, Pedersen SB. 2014. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. J Clin Endocrinol Metab. 99:4720–4729.10.1210/jc.2014-2799
   PubMed Web of Science ®Google Scholar
• Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, et al. 2010. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 70:7392–7399.10.1158/0008-5472.CAN-10-2027
   PubMed Web of Science ®Google Scholar
• Péry AR, Brochot C, Zeman FA, Mombelli E, Desmots S, Pavan M, Fioravanzo E, Zaldívar JM2013. Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: a case study with acetaminophen. Toxicol Lett. 220:26–34.10.1016/j.toxlet.2013.03.032
   PubMed Web of Science ®Google Scholar
• Petyaev IM, Bashmakov YK. 2012. Could cheese be the missing piece in the French paradox puzzle? Med Hypotheses. 79:746–749.10.1016/j.mehy.2012.08.018
   PubMed Web of Science ®Google Scholar
• Pirola L, Fröjdö S. 2008. Resveratrol: one molecule, many targets. IUBMB Life. 60:323–332.10.1002/(ISSN)1521-6551
   PubMed Web of Science ®Google Scholar
• Poulin P, Burczynski FJ, Haddad S. 2015. The role of extracellular binding proteins in the cellular uptake of drugs: impact on quantitative in vitro-to-in vivo extrapolations of toxicity and efficacy in physiologically based pharmacokinetic-pharmacodynamic research. J Pharm Sci. 105:497–508.
   Web of Science ®Google Scholar
• Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stodkilde-Jorgensen H, Moller N, Jessen N, Pedersen SB, Jorgensen JO. 2013. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes. 62:1186–1195.10.2337/db12-0975
   PubMed Web of Science ®Google Scholar
• Rana J, Diwakar G, Saito L, Scholten JD, Mulder T. 2013. Inhibition of melanin content by Punicalagins in the super fruit pomegranate (Punica granatum). J Cosmet Sci. 64:445–453.
   PubMed Web of Science ®Google Scholar
• Rayalam S, Yang JY, Della-Fera MA, Park HJ, Ambati S, Baile CA. 2009. Anti-obesity effects of xanthohumol plus guggulsterone in 3T3-L1 adipocytes. J Med Food. 12:846–853.10.1089/jmf.2008.0158
   PubMed Web of Science ®Google Scholar
• Renaud S, de Lorgeril M. 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1523–1526.10.1016/0140-6736(92)91277-F
   PubMed Web of Science ®Google Scholar
• Rossi T, Gallo C, Bassani B, Canali S, Albini A, Bruno A. 2014. Drink your prevention: beverages with cancer preventive phytochemicals. Pol Arch Med Wewn. 124:713–722.
   PubMed Web of Science ®Google Scholar
• Sahebkar A. 2013. Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 71:822–835.10.1111/nure.2013.71.issue-12
   PubMed Web of Science ®Google Scholar
• Sale S, Verschoyle RD, Boocock D, Jones DJ, Wilsher N, Ruparelia KC, Potter GA, Farmer PB, Steward WP, Gescher AJ. 2004. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4’-tetramethoxystilbene. Br J Cancer. 90:736–744.10.1038/sj.bjc.6601568
   PubMed Web of Science ®Google Scholar
• Samitz G, Egger M, Zwahlen M. 2011. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol. 40:1382–1400.10.1093/ije/dyr112
   PubMed Web of Science ®Google Scholar
• Samsami-Kor M, Daryani NE, Asl PR, Hekmatdoost A. 2015. Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 46:280–285.
   PubMed Web of Science ®Google Scholar
• Savouret JF, Quesne M. 2002. Resveratrol and cancer: a review. Biomed Pharmacother. 56:84–87.10.1016/S0753-3322(01)00158-5
   PubMed Web of Science ®Google Scholar
• da Silva Santos V, de Almeida Teixeira GH, Barbosa F Jr. 2014. Acai (Euterpe oleracea Mart.): a tropical fruit with high levels of essential minerals-especially manganese-and its contribution as a source of natural mineral supplementation. J Toxicol Environ Health A. 77:80–89.10.1080/15287394.2014.866923
   PubMed Web of Science ®Google Scholar
• Stevens JF, Page JE. 2004. Xanthohumol and related prenylflavonoids from hops and beer: to your good health!. Phytochem. 65:1317–1330.10.1016/j.phytochem.2004.04.025
   PubMed Web of Science ®Google Scholar
• Stevens JF, Taylor AW, Deinzer ML. 1999. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 832:97–107.10.1016/S0021-9673(98)01001-2
   PubMed Web of Science ®Google Scholar
• Tagawa N, Kubota S, Kato I, Kobayashi Y. 2013. Resveratrol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes. J Endocrinol. 218:311–320.10.1530/JOE-13-0066
   PubMed Web of Science ®Google Scholar
• Thazhath SS, Wu T, Bound MJ, Checklin HL, Standfield S, Jones KL, Horowitz M, Rayner CK. 2016. Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. Am J Clin Nutr. 103:66–70.10.3945/ajcn.115.117440
   PubMed Web of Science ®Google Scholar
• Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, et al. 2011. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14:612–622.10.1016/j.cmet.2011.10.002
   PubMed Web of Science ®Google Scholar
• van der Made SM, Plat J, Mensink RP. 2015. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial. PLOS ONE. 10:e0118393.10.1371/journal.pone.0118393
   PubMed Web of Science ®Google Scholar
• Vidavalur R, Otani H, Singal PK, Maulik N. 2006. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol. 11:217–225.
   PubMedGoogle Scholar
• Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R. 2005. Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res. 49:495–504.10.1002/(ISSN)1613-4133
   PubMed Web of Science ®Google Scholar
• Vitrac X, Desmoulière A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Mérillon JM. 2003. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 72:2219–2233.10.1016/S0024-3205(03)00096-1
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 32:1377–1382.10.1124/dmd.104.000885
   PubMed Web of Science ®Google Scholar
• Wang LX, Heredia A, Song H, Zhang Z, Yu B, Davis C, Redfield R. 2004. Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity. J Pharm Sci. 93:2448–2457.10.1002/jps.20156
   PubMed Web of Science ®Google Scholar
• Wang Y, Lee KW, Chan FL, Chen S, Leung LK. 2006. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol Sci. 92:71–77.10.1093/toxsci/kfj190
   PubMed Web of Science ®Google Scholar
• Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FB. 2014. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 349:g4490.10.1136/bmj.g4490
   PubMed Web of Science ®Google Scholar
• Warburton DE, Nicol CW, Bredin SS. 2006. Health benefits of physical activity: the evidence. CMAJ. 174:801–809.10.1503/cmaj.051351
   PubMed Web of Science ®Google Scholar
• Wollschlaeger B. 2003. The dietary supplement and health education act and supplements: dietary and nutritional supplements need no more regulations. Int J Toxicol. 22:387–390.10.1177/109158180302200509
   PubMed Web of Science ®Google Scholar
• Wong RH, Berry NM, Coates AM, Buckley JD, Bryan J, Kunz I, Howe PR. 2013. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens. 31:1819–1827.10.1097/HJH.0b013e328362b9d6
   PubMed Web of Science ®Google Scholar
• Xiang L, Xiao L, Wang Y, Li H, Huang Z, He X. 2014. Health benefits of wine: don’t expect resveratrol too much. Food Chem. 156:258–263.10.1016/j.foodchem.2014.01.006
   PubMed Web of Science ®Google Scholar
• Xie Z, Sintara M, Chang T, Ou B. 2015. Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: a randomized, double-blind, placebo-controlled clinical trial. Food Sci Nutr. 3:342–348.10.1002/fsn3.225
   PubMed Web of Science ®Google Scholar
• Yang JY, Della-Fera MA, Rayalam S, Baile CA. 2007. Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis. 12:1953–1963.10.1007/s10495-007-0130-4
   PubMed Web of Science ®Google Scholar
• Yoon M, Campbell JL, Andersen ME, Clewell HJ. 2012. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Crit Rev Toxicol. 42:633–652.10.3109/10408444.2012.692115
   PubMed Web of Science ®Google Scholar
• Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Fanelli F, Patterson BW, et al. 2012. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 16:658–664.10.1016/j.cmet.2012.09.015
   PubMed Web of Science ®Google Scholar
• Zheng H, Yde CC, Clausen MR, Kristensen M, Lorenzen J, Astrup A, Bertram HC. 2015. Metabolomics investigation to shed light on cheese as a possible piece in the french paradox puzzle. J Agric Food Chem. 63:2830–2839.10.1021/jf505878a
   PubMed Web of Science ®Google Scholar
• Zortea K, Franco VC, Francesconi LP, Cereser KM, Lobato MI, Belmonte-de-Abreu PI. 2016. Resveratrol supplementation in schizophrenia patients: a randomized clinical trial evaluating serum glucose and cardiovascular risk factors. Nutrients. 8:73–82.
   PubMed Web of Science ®Google Scholar